ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
II
IRCCS Institute of Neurological Sciences of Bologna at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
IRCCS Institute of Neurological Sciences of Bologna takes part in 3 sessions at ESMO 2026 in Madrid. Its work centres on brain tumours and head and neck cancer. It examines how patient selection can explain apparent benefits of later treatment in glioblastoma, and the potential significance of a target found in gliomas.
| Organization | ESMO 2026 Attendance |
|---|---|
II IRCCS Institute of Neurological Sciences of Bologna Bologna, Italy | |
Neurological research and treatment institute in Bologna, Italy. | Poster Fri Oct 23 13:00–15:00 Challenging the paradigm: p53 alteration reveals heterogeneity within molecularly confirmed HPV-driven OPSCC- The CARMA study Sarcoma, CNS, head & neck and rare cancersBiomarkers & precision oncology Poster Sat Oct 24 12:00–12:45 Apparent benefit of later-line therapy in glioblastoma is largely driven by patient selection Sarcoma, CNS, head & neck and rare cancers Poster Sat Oct 24 12:00–12:45 PSMA expression in adult-type diffuse gliomas: Neuropathological insights and theranostic implications Sarcoma, CNS, head & neck and rare cancersBiomarkers & precision oncology Chair Sun Oct 25 10:15–11:45 Proffered paper: CNS tumours Sarcoma, CNS, head & neck and rare cancers |
Find decision makers at IRCCS Institute of Neurological Sciences of Bologna
Tell us what you sell and we’ll find the people at IRCCS Institute of Neurological Sciences of Bologna most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction